Insights into clear cell renal cell carcinoma microenvironment: LOXL2 expression and topographical layout of CD3+ T lymphocytes

INTRODUCTION: Lysyl oxidase-like 2 (LOXL2) is involved in extracellular matrix remodeling and has been implicated in renal cancer progression. However, its relationship with clinicopathological characteristics and the topographical layout of CD3+ T lymphocytes in clear cell renal cell carcinoma (ccRCC) remains incompletely understood. MATERIAL AND METHODS: This retrospective study included 113 consecutive surgically resected ccRCCs. Tumoral LOXL2 expression was assessed immunohistochemically using a semiquantitative scoring system, considering the proportion of positive tumor cells, staining intensity, and low/high expression categories. CD3+ T cell infiltration was evaluated separately in intratumoral and peritumoral compartments, and a compartmental difference was calculated. Associations with clinicopathological characteristics and CD3+ infiltration were investigated using appropriate statistical analyses. RESULTS: Low LOXL2 expression was identified in 79 tumors (69.9%) and high expression in 34 (30.1%). CD3+ infiltration showed an overall peritumoral predominance (p = 0.002). No significant differences in CD3+ infiltration were identified between LOXL2-LOW and LOXL2-HIGH tumors. However, LOXL2 staining intensity was positively correlated with peritumoral CD3+ infiltration (ρ = 0.328, p < 0.001) and negatively correlated with the intratumoral-peritumoral CD3+ difference (ρ = -0.396, p < 0.001). Both associations remained significant after correction for multiple comparisons. In contrast, the proportion of LOXL2-positive tumor cells showed no significant correlations with CD3+ infiltration. CONCLUSIONS: LOXL2 staining intensity was associated with variations in the topographical organization of CD3+ T lymphocyte infiltration in ccRCC, particularly within the peritumoral compartment. These findings suggest a relationship between LOXL2 immunoreactivity and the organization of the tumor immune microenvironment, supporting further investigation of extracellular matrix-associated mechanisms in ccRCC.

Authors

Institutions

Publication Details

Journal
Folia Histochemica et Cytobiologica
Published
2026-11-13
DOI
https://doi.org/10.5603/fhc.115576
Primary Topic
Renal cell carcinoma treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Insights into clear cell renal cell carcinoma microenvironment: LOXL2 expression and topographical layout of CD3+ T lymphocytes

Andreea Rusu, Irina-Draga Caruntu, Constantin Aleodor Costin, Bogdan Toma et al.
1 links
Folia Histochemica et Cytobiologica
Renal cell carcinoma treatment
article

Insights into clear cell renal cell carcinoma microenvironment: LOXL2 expression and topographical layout of CD3+ T lymphocytes

Andreea Rusu, Irina-Draga Caruntu, Constantin Aleodor Costin, Bogdan Toma, Mariana Bianca Chifu, Andrei Daniel Timofte, Simona Giusca, Ana-Maria Gradinaru
article en

Abstract

INTRODUCTION: Lysyl oxidase-like 2 (LOXL2) is involved in extracellular matrix remodeling and has been implicated in renal cancer progression. However, its relationship with clinicopathological characteristics and the topographical layout of CD3+ T lymphocytes in clear cell renal cell carcinoma (ccRCC) remains incompletely understood. MATERIAL AND METHODS: This retrospective study included 113 consecutive surgically resected ccRCCs. Tumoral LOXL2 expression was assessed immunohistochemically using a semiquantitative scoring system, considering the proportion of positive tumor cells, staining intensity, and low/high expression categories. CD3+ T cell infiltration was evaluated separately in intratumoral and peritumoral compartments, and a compartmental difference was calculated. Associations with clinicopathological characteristics and CD3+ infiltration were investigated using appropriate statistical analyses. RESULTS: Low LOXL2 expression was identified in 79 tumors (69.9%) and high expression in 34 (30.1%). CD3+ infiltration showed an overall peritumoral predominance (p = 0.002). No significant differences in CD3+ infiltration were identified between LOXL2-LOW and LOXL2-HIGH tumors. However, LOXL2 staining intensity was positively correlated with peritumoral CD3+ infiltration (ρ = 0.328, p < 0.001) and negatively correlated with the intratumoral-peritumoral CD3+ difference (ρ = -0.396, p < 0.001). Both associations remained significant after correction for multiple comparisons. In contrast, the proportion of LOXL2-positive tumor cells showed no significant correlations with CD3+ infiltration. CONCLUSIONS: LOXL2 staining intensity was associated with variations in the topographical organization of CD3+ T lymphocyte infiltration in ccRCC, particularly within the peritumoral compartment. These findings suggest a relationship between LOXL2 immunoreactivity and the organization of the tumor immune microenvironment, supporting further investigation of extracellular matrix-associated mechanisms in ccRCC.

Folia Histochemica et Cytobiologica
Grigore T. Popa University of Medicine and Pharmacy (RO), Spitalul Clinic Dr. C. I. Parhon (RO)
Good health and well-being
Renal cell carcinoma treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon